Drugs / HRF2105
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06047483 | Oct → Dec 2023 | — | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRF2105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06047483 ↗ |
| Route | Topical | “external use” NCT06047483 ↗ |